"The Clinical Research Center of the Carolinas has attained national renown for its contributions to dermatological and medical research for nearly two decades. Founded by Dr. Todd Schlesinger, the center’s team of physicians, physician assistants, and clinical research coordinators partner with pharmaceutical and medical device companies and other research organizations to conduct clinical trials of new or improved medicines and medical devices to expand treatment options for patients and alleviate illness and suffering."

During the past decade, Clinical Research Center of the Carolinas conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 13 clinical trials were completed, i.e. on average, 43.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 13 clinical trials were completed. i.e. 72.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Center of the Carolinas" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Biofrontera Bioscience GmbH" with 3 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Concert Pharmaceuticals" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Center of the Carolinas" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Center of the Carolinas" are "Atopic Dermatitis" (7 trials), "Psoriasis" (5 trials), "Alopecia Areata" (3 trials), "Plaque Psoriasis" (3 trials) and "Actinic Keratosis" (2 trials). Many other conditions were trialed in "Clinical Research Center of the Carolinas" in a lesser frequency.

Most popular intervention types in "Clinical Research Center of the Carolinas" are "Drug" (23 trials), "Biological" (4 trials), "Combination Product" (3 trials), "Other" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Lebrikizumab" (3 trials), "Apremilast" (2 trials), "BMS-986165" (2 trials) and "CTP-543" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Center of the Carolinas" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research Center of the Carolinas". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in Clinical Research Center of the Carolinas, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Center of the Carolinas, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".